Activist Alchemy: How $101M Bet on Indivior Became a 212% Windfall 🚀

Let us dissect this financial sorcery with the precision of a surgeon general’s scalpel. Indivior’s shares, once languishing in the shadow of pharmaceutical giants, have rocketed 212% skyward-a trajectory that shames the S&P 500’s timid 13% crawl. Newtyn, ever the opportunist, now holds 1.6 million more shares than a quarter prior, their 12.4% portfolio bet screaming “This way to the money!” louder than a Wall Street crier hawking penny stocks.




